Brass Tacks Health

The BTH team is heading to Chicago today to join more than 40,000 oncology professionals from around the world for the annual meeting of the American Society of Clinical Oncology (#ASCO2024). Over 5,000 presentations on advances in oncology research at this conference! Get in touch if you'd like to discuss our take on the most promising therapies in development. info@brasstackshealth.com #immunotherapy #trendsinoncology #tcellengagers #precisionmedicine #targetedtherapy #melanoma #nsclc #individualizedneoantigentherapy #celltherapies #combinationtherapies #antibodydrugconjugates #competitiveintelligence Vanessa Nguyen, PhD, Jilliane Perkins, Eileen Faucher

In her latest Forbes article, Eileen Faucher explains the business case for expanding diversity in clinical trials. At BTH, we have developed methodologies to gain insights into best practices in this regard. Reach out to learn how better patient representation in clinical trials can be a lever of sustained competitive advantage. Eileen@brasstackshealth.com #competitiveintelligence #forbes #healthequity #clinicaltrialdiversity

The Brass Tacks team is delighted to be at the Life Science Innovation Northwest conference again today. Looking forward to connecting with our PNW colleagues, old and new! Drop by to chat about your market planning, to say hi or just to grab a BTH chocolate cookie. They’re actually really good ;) #lsinw #lifesciencewashington #community #chocolatecookies Vanessa Nguyen, PhD Jilliane Perkins

Are you at AACR? BTH is in San Diego this week covering the latest developments in cancer research. Get in touch to hear our take on the implications for your competitive readiness planning...Or to just say hi! #AACR2024 info@brasstackshealth.com #immunotherapy #trendsinoncology #tcellengagers #precisionmedicine #targetedtherapy #melanoma #nsclc #celltherapies #antibodydrugconjugates #competitiveintelligence Jilliane Perkins Vanessa Nguyen, PhD

Welcome to the team, Jilliane Perkins!

As we enter 2024, we want to extend our gratitude to our colleagues and clients. We appreciate your confidence in us and look forward to our ongoing thought partnership in the New Year. We are here to support you every step of the way. A special thanks for your referrals, which have been instrumental to our growth. If there is anyone in your circle who could benefit from our expertise, we would be honored to have your recommendation. Sending our warmest wishes to all! May your 2024 be a year filled with great health, peace and prosperity. 

BTH will be in SF next month, supporting clients with the most up-to-date due diligence as they head into their JPM meetings. Drop us a line if you would like some specialized support with your JPM prep! Curating clinical data and commercial landscapes into meaningful narratives is our specialty. info@brasstackshealth.com #immunotherapy #trendsinoncology #tcellengagers #precisionmedicine #targetedtherapy #bispecifics #solidtumors #hematology #neoantigentherapy #celltherapies #combinationtherapies #antibodydrugconjugates  #competitiveintelligence

The BTH team is looking forward to connecting with colleagues, old and new, in San Diego later this week, at the 38th annual meeting of the Society of Immunotherapy of Cancer (#SITC2023). If you'd like to discuss the most promising therapies in development, or our perspective on why and how to make clinical trials more accessible, please reach out and let's set up a time to chat. info@brasstackshealth.com #immunotherapy #trendsinoncology #tcellengagers #precisionmedicine #targetedtherapy #melanoma #nsclc  #individualizedneoantigentherapy #celltherapies #combinationtherapies #antibodydrugconjugates  #competitiveintelligence Aurora Chen, MBA, MPH Vanessa Nguyen, PhD Eileen Faucher

Would you like a summary of our key highlights from annual congress of the European Society of Medical Oncology (ESMO) 2023? We will be live in Madrid, October 20-24. To hear our insights on where the standard of care is headed for patients with cancer, and how to think outside the box when it comes to competitive readiness planning, just drop us a line.  #competitiveintelligence #esmo2023 info@brasstackshealth.com

In her talk last week at Pharma CI 2023, Eileen Faucher explains the business case for adding clinical trial diversity to your CI insights, and shares a few examples of methodologies we have developed at Brass Tacks to deduce which studies are most likely to be enrolling patient populations that reflect the real-world demographic of the patients being served. Eileen will be taking this talk on the road in the first half of 2024! If you think your organization might have interest, please reach out to arrange. info@brasstackshealth.com #pharmaci #pharmaciconf #pharmaciconference #diversityinclinicaltrials #equityandaccess #brasstackshealth